20th Annual Mergers & Acquisitions Outlook Survey

Executive Summary

In the two decades that Dykema has surveyed dealmakers about the U.S. M&A landscape, one dominant theme has emerged: the M&A market is only as strong (or weak) as the underlying economy. Hence the nadir in 2008, the subsequent, steady rise in M&A dealmaking environment during the period of low interest rates that followed, and other events that impacted the overall economy, including fluctuations amid pivotal election years, regulatory evolutions, and, of course, the COVID-19 pandemic.

The question, then, for respondents to Dykema’s 2024 M&A Outlook Survey—our 20th-anniversary edition—is what’s next? The more than 200 dealmakers who took this year’s survey in July and August, including C-suite executives, senior management, bankers, and private equity (PE) professionals at organizations of all sizes across the country, have answers.

Thomas S. Vaughn   

Big picture: as the economy goes, so goes M&A.

Thomas S. Vaughn
Former Co-Leader of Dykema’s M&A Practice

The last three years saw record M&A highs in 2021 and early 2022, followed by a lackluster 2023 as the Federal Reserve hiked rates in response to inflation rose. According to the survey, 2024 and 2025 show signs of a comeback. Seventy percent of respondents said the U.S. M&A market will strengthen in the next 12 months; only 9% said it would weaken. This, our survey tells us, is largely driven by the positive elements of financial market conditions, availability of capital, and general economic conditions such as stabilizing inflation and reduced interest rate levels*—the same top factors that respondents say impacted M&A opportunities over the past 12 months.

The findings make sense given the resilient U.S. economy, which has seen no real slowdown in consumer spending, a strong labor market, and business leaders looking to invest in innovative startups and adopt technologies like Artificial Intelligence (AI). But it’s not all rosy. Uncertain market and economic conditions are also the top two factors that respondents say will present hurdles for M&A in the next 12 months—understandable, given ongoing anxiety about the timing of interest rate reductions and the result of the upcoming election.

The interest rate environment has been a key factor in limiting M&A.

Frank Ballantine
Member

  Thomas S. Vaughn 

Still, there are other avenues for dealmakers. “The interest rate environment has been a key factor in limiting M&A,” says Frank Ballantine, Dykema Member who leads M&A and other corporate finance transactions on behalf of businesses and investors. “But capitalism is like water—it finds the gaps of opportunity. Hedge funds and private credit organizations have filled the space left by creating opportunities for private and PE-backed companies to keep growing their businesses.”

There are new regulatory impacts, too: in response to heightened deal scrutiny and new merger guidelines rules from the antitrust enforcers—the Federal Trade Commission (FTC) and the Department of Justice, Antitrust Division—the vast majority of dealmakers say that they have increased their scrutiny of target companies for potential antitrust risk the past year (80%) and will continue to do so in the coming year (75%). Over half say the FTC’s merger review process has impeded (and will impede) deal activity.

For its part, private equity has plenty of capital on hand. Sixty-Nine percent of respondents say PE investors will boost deal activity in the next 12 months—but long hold periods, misaligned valuations, and economic volatility are undermining their ability to put that capital to work and profitably exit existing investments.

Finally, this year’s report delves into key dealmaking sectors. Artificial Intelligence (AI), not surprisingly, has made its way to the top of everyone’s list with, nearly three-quarters of respondents believing that  buyers will target companies with AI solutions, operating companies that have implemented AI solutions, and those providing AI infrastructure, such as data centers or chips manufacturers. Meanwhile, energy, financial services, and healthcare are once again expected to be the most active sectors in the year ahead, though healthcare has replaced energy as the sector that respondents say will experience the most M&A activity—largely as a result of the drive for efficiency improvements. These three sectors—again, led by healthcare—have been the most active throughout our 20 years of industry rankings.

In what follows, we’ll unpack these findings and take a deeper dive into the report’s key themes and sector-specific insights, including AI, private equity, healthcare, energy, automotive, and more.

Key Findings

Here are the major takeaways from this year’s survey. Click the “+” to read more.

Seventy percent of respondents said that the U.S. M&A market will strengthen in the next 12 months, largely due to financial market conditions (42%), general economic conditions (36%), and availability of capital (35%). Company valuations and the availability of quality targets are also increasingly important drivers of M&A. 

There’s still plenty of economic uncertainty out there, with respondents citing general economic conditions (39%) and financial market conditions (35%) as the top two factors posing obstacles to deal activity in the next year. Buyer competition (29%) and company valuations (28%) are also key factors.

Over half of respondents (56%) believe the FTC’s merger review process will impede deal activity in the next year, and 75% say dealmakers will increase their scrutiny of target companies based on anti-trust considerations.

Nearly 70% of respondents say PE investors will boost deal activity, but economic volatility and limited exit opportunities may deter them from deploying dry powder.

Nearly three-quarters of respondents believe buyers will target companies with AI solutions, operating companies that have implemented AI solutions, and those companies offering AI infrastructure in the next 12 months. 

Though 55% of respondents still expect dealmakers to seek targets that will boost ESG performance in the next year, this is down from the year prior—and roughly a third now say (versus 19% in 2023) that it is unlikely they will work on a deal where the target company or buyer is screened for ESG risk.

Healthcare M&A will largely be driven by the need for efficiency improvements, whereas renewables are expected to continue to spur activity in the energy sector.